The food and beverage industry has framed GLP-1 as a volume problem. People are eating less—adjust accordingly. Smaller portions. Lower calorie counts. “GLP-1 friendly” on the label.
That’s the wrong diagnosis. And brands building strategy around it are solving for a symptom while missing the condition entirely.
GLP-1 doesn’t just reduce hunger. It acts along the same mental pathways that activate—or deactivate—desire for anything: food, drink, vice, even love, as emerging research finds. It changes the permission structure for acting on what we used to want without thinking about it. Researchers are finding that GLP-1 tamps down all receptors for wanting—which means the impulsive shopper, the absent-minded reach, the cart addition that didn’t require a decision—that behavior may simply stop. Not slow down. Stop.
Eating becomes deliberate where it used to be reflexive. Pleasure becomes something people actively decide to allow—rather than something appetite authorizes by default. That is not a portion-size problem. That is a brand relationship problem. And it touches every category that has ever built equity on desire, comfort, ritual, or reward: food, beverage, vitamins, supplements, personal care. Any brand that has relied on the unconscious “yes” needs to be paying attention.
We have not reached equilibrium. The cultural norms around GLP-1 use are still forming in real time—no shared social script for how you talk about it at dinner, no settled consensus on what it means or doesn’t mean about a person. The oscillation GLP-1 users describe—between discipline and longing, between I don’t want it and I miss wanting it—doesn’t resolve neatly. It has become its own cultural condition. Brands designing for a settled consumer are designing for someone who doesn’t exist yet.
At LPK, we’ve been tracking four consumer tensions shaping what comes next. None of them are theoretical. All of them are already moving.
Control vs. The Body You Don’t Recognize
GLP-1 gives people more pharmacological control over their own body than they’ve ever had access to—and that control is genuinely wanted. But the body doesn’t always cooperate with the plan. Rapid changes in body mass affect skin elasticity, hair and nail integrity, and the hormonal ecosystem in ways that move faster than most consumers anticipate—and faster than most brands have formulated for. The person who wanted sovereignty over her body is now looking in the mirror at skin that isn’t keeping pace, or hair that’s telling her something her labs haven’t flagged yet.
Control was the goal. The body changing faster than she can manage it is the unexpected cost.
Emerging research on GLP-1’s role in modulating hormone balance adds another layer—with downstream effects on skin hydration, oil production, and cellular repair that the beauty and personal care industry is only beginning to map. Meanwhile, the shared meal, the bottle opened at the table, the occasion that doesn’t work without something in everyone’s hand — these social contracts are being quietly renegotiated too. The insight that keeps surfacing in our research: I want sovereignty over my body—but I don’t want to opt out of life.
If brands treat GLP-1 as purely a nutrition or volume problem, what they’ll actually experience is subtler than a sales drop. Rituals shrink. Emotional relevance erodes quietly—and then suddenly. The diagnostic question every brand should be asking: are you essential to the moment, or only essential when someone’s hungry? Because the body transforming faster than the brand can respond is a version of the same problem—and portion sizes and existing formulations won’t solve either one.
Pleasure vs. Permission—and Efficacy vs. Tolerance
If hunger no longer provides permission, culture fills the gap with judgment. Visible restraint has become a social signal. Indulgence has become something to justify—earned through discipline or defended through nutritional credentials. The consumer didn’t used to need a permission slip. Now she does.
For food and beverage brands, the brands that win this tension aren’t adding health claims. They’re removing the need for them—high sensory impact at lower volume, no moral framing anywhere in the brand experience, pleasure that feels safe not because it’s been certified but because the brand relationship itself communicates trust. Brands that don’t consciously position on the permission side of this tension end up on the guilt side by default. And guilt has a very short shelf life.
For VMS and personal care, the permission tension has a different shape: it’s the tension between efficacy claims and what the GLP-1 body can actually use. GLP-1 slows gastric emptying—which changes how nutrients are absorbed, how supplements are metabolized, and how the gut microbiome responds to inputs it used to handle without incident. A supplement formulated for a pre-GLP-1 gut may simply not perform the same way in a GLP-1 gut. Efficacy claims built on pre-GLP-1 clinical data may be quietly, meaningfully wrong.
This is a significant liability for brands that don’t address it—and a real opportunity for brands that do. Sensitive stomach-friendly formulations, adjusted delivery mechanisms, bioavailability designed for altered absorption—these aren’t niche claims. They’re the product truth a rapidly growing consumer segment needs someone to help them navigate not just the shelf but their changing body. The GLP-1 consumer already feels like her body requires more active management than it used to. A supplement that causes GI distress in a gut that is already more reactive doesn’t just lose a repurchase. It confirms her suspicion that she has to choose between the medication working and everything else working.
Optimization vs. What the Body Can Actually Use
Wellness culture is loud about optimization—maximum absorption, clinical-strength dosing, loading the body with what it needs to perform. But a GLP-1 body eating significantly less is getting fewer total nutrients across the board and absorbing them differently. The optimization brief and the physiological reality are increasingly in conflict.
GLP-1 users frequently describe what we’re calling the soft food trap—gravitating toward toast, plain chicken, mild soups. Not because they want to. Because those are the things that don’t cause problems. Hair thinning and nail brittleness from reduced total nutrient intake, skin laxity from rapid fat loss, depleted barrier function from shifting hormone profiles—these are the consequences of the soft food trap that no one in the supplement or personal care aisle is yet speaking to clearly or formulating for specifically.
The skincare opportunity is particular and underreported. GLP-1’s emerging influence on hormone modulation has implications for skin barrier function, cellular hydration, and oil-water balance that most brands haven’t begun to address—in formulation or in communication. A consumer whose hormone profile is shifting and whose nutrient intake has dropped has skin that is changing at a cellular level, not just a surface level.
What looks like a preference change in this consumer is often a tolerance change. The wellness response—louder optimization signals, more performance claims, more functional credentials—is exactly wrong for a body that needs reliability, not challenge. Comfort, in this context, is the product that works with the body’s current operating system, not the one it had before. That’s a design brief, not a positioning statement. And it’s largely unanswered across every category in this space.
Abstention vs. Identity—and Who She’s Becoming
Addiction specialists are already describing GLP-1 as a reconceptualization of addiction itself—suggesting it may be quieting appetite as a category, not just appetite for food. The person who used to want things differently will need new ways to want.
For food and beverage, the identity risk arrives quietly—well before the sales data shows it. When the unconscious yes disappears, consumption becomes conscious. And conscious consumption, in a culture already saturated with food moralization and wellness surveillance, defaults to scrutiny. The consumer who used to reach for your product without thinking now pauses, weighs, and decides. And in that moment of decision, the question she’s asking isn’t do I want this—it’s is this the kind of thing someone like me chooses. When the answer becomes uncertain, the brand has already lost the identity conversation. Discounts, promos, and pricing become a lever of last resort to get her to say yes. But, a cultural narrative about abstention fills the decision vacuum the brand left open.
For personal care and VMS, the identity opportunity is distinct. Hair, skin, and nails are identity-visible. They’re the part of the transformation that other people see and comment on—and they’re often the part that lags or quietly struggles when total nutrient quality drops or hormone balance shifts. The consumer celebrating a body transformation may simultaneously be managing consequences of it that don’t fit the public narrative: hair that’s shedding, skin that looks depleted rather than renewed, nails that have become fragile. These are not small vanity concerns. They are signals that her body is working hard and not getting everything it needs to keep pace.
Brands that show up honestly in that gap—with formulations designed for the nutrients she’s no longer getting from food, with skincare that speaks to cellular repair rather than surface glow, with a brand voice that acknowledges transformation is complicated—are positioned to own an identity story that food and beverage brands simply cannot access from where they sit.
The opportunity is that none of this is inevitable. Brands that move on the identity question now—at the brand level, not the SKU level—are the ones that won’t find themselves in a defensive posture in 2028.
What Comes Next
GLP-1 is the most visible signal of something larger: a culture that has decided the body is the one project with a traceable outcome in a world where most other projects feel uncontrollable. That context reshapes competition across every category in this piece. Food and beverage brands are largely playing defense—protecting ritual, protecting permission, protecting the emotional equity that GLP-1 is quietly eroding. VMS and personal care brands are playing a different game entirely.
The body is changing. The consumer knows it. She is actively looking for brands that have been thinking about what she needs next—before she had the language to ask for it. That’s not a line extension. That’s a category leadership opportunity.
The question LPK is bringing to every brand conversation in this space isn’t how do you adjust for GLP-1 users. It’s simpler and harder than that.
In a world where appetite is optional—what does your brand mean?
Because just appetite was never the point.
ABOUT LPK
LPK is a modern brand consultancy working with ambitious food, beverage, and health and personal care brands navigating the next wave of consumer change. If this taps into questions you’ve been sitting with, let’s turn that into a conversation.
